GlassScriptPhysician profile
Gerald Ds Goldberg
NPI 1184698953
$3,409.51
in general payments reported to CMS, 2019-2025
41 companies · $1,662 in 2025
The $1,662 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $95.34 · 2021: $204 · 2022: $89.05 · 2023: $322 · 2024: $891 · 2025: $1,662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,874.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,873.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $846.91 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $257.64 | 2024-2025 | Rexulti |
| Lundbeck LLC | $243.92 | 2023-2025 | Vyepti, Rexulti |
| Amgen INC. | $191.62 | 2019-2025 | Uplizna |
| Biogen, INC. | $187.39 | 2025 | Tysabri, Vumerity, Skyclarys |
| Emd Serono, INC. | $177.50 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $140.17 | 2023-2025 | Austedo Xr, Austedo Xr |
| Pfizer INC. | $110.16 | 2024-2025 | |
| Axsome Therapeutics, INC. | $103.46 | 2025 | Symbravo |
| Ucb, INC. | $98.98 | 2025 | Fintepla, Rystiggo |
| Acadia Pharmaceuticals INC | $77.30 | 2024-2025 | Nuplazid |
| Takeda Pharmaceuticals U.S.A., INC. | $67.88 | 2025 | Hyqvia |
| Tanabe Pharma America, INC. | $64.33 | 2023 | |
| Akcea Therapeutics, INC. | $62.56 | 2020 | |
| Csl Behring | $60.58 | 2024-2025 | Hizentra |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Goldberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.